Thanks SF. In my research it is becoming clear that the MM products for epilepsy are not a one size fits all on both counts. That is the mm products are unique formulations which work on specific epilepsy conditions. GW product was targeting two very rare forms yet gets promoted as epilepsy drug as if it deals with all forms. Tilrays while it seems to be a small test samples sounds as if it is for a broader range so could well be direct competition...
- Forums
- ASX - By Stock
- Cannepil
Thanks SF. In my research it is becoming clear that the MM...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.0¢ |
Change
0.015(2.80%) |
Mkt cap ! $26.62M |
Open | High | Low | Value | Volume |
50.0¢ | 55.0¢ | 40.5¢ | $9.135K | 17.05K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 679 | 51.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 24 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 0.405 |
1 | 1000 | 0.360 |
1 | 2000 | 0.350 |
1 | 12000 | 0.340 |
1 | 1633 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.550 | 1527 | 1 |
0.570 | 9732 | 1 |
0.575 | 214 | 1 |
0.590 | 2000 | 1 |
0.650 | 45000 | 1 |
Last trade - 14.16pm 04/10/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |